Spread of Multidrug-Resistant Microorganisms, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 20 December 2024 | Viewed by 242
Special Issue Editors
Interests: antimicrobial, anti-biofilm and anti-virulence activities of bioactive substances of natural origin; semi-synthesis and innovative biomaterials; the research activity has concerned oral cavity microorganisms
Special Issues, Collections and Topics in MDPI journals
Interests: antimicrobial; anti-biofilm and anti-virulence activities of natural compounds alone and combined with antibiotics against multi drug-resistant strains (Helicobacter pylori, Staphylococcus spp., Pseudomonas aeruginosa, Candida albicans, Mycobacterium abscessus and other fast-growing mycobacteria)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first edition of the Special Issue “Spread of Multidrug-Resistant Microorganisms” was published in 2021. It is a successful collection comprising 11 excellent papers. This encouraged us to open a second edition on the same topic.
As a continuation of the first Special Issue, this second edition focuses on the epidemiology of MDROs, the activity of new antimicrobials, implication of various determinants of resistance and strategies to control the diffusions of MDROs. Researchers working in this field are encouraged to submit their best manuscript(s) to this Special Issue.
Dr. Mara Di Giulio
Dr. Silvia Di Lodovico
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug-resistant organisms
- MDR
- antibiotic resistance gene
- nosocomial infections
- new marker of resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Spread of Multidrug-Resistant Microorganisms in Antibiotics (11 articles)
